banner
Pawg khoom
Tiv tauj peb

Hu rau:Errol Zhou (Mr.)

Tel: ntxiv 86-551-65523315

Mobile/WhatsApp: ntxiv 86 17705606359

QQ:196299583

Skype:lucytoday@hotmail.com

Email:sales@homesunshinepharma.com

Ntxiv:1002, Huanmao Tsev, No.105, Mengcheng Txoj kev, Hefei Lub zos, 230061 Tuam Tshoj

APIs thiab Intermediates
2-Piperidin-4-yl-1H-benzoimidazole CAS 38385-95-4

2-Piperidin-4-yl-1H-benzoimidazole CAS 38385-95-4

CAS TSIS TAU: 38385-95-4


Cov Qauv Nqaij: C12H15N3


Cov Nqa Molecular: 201.268


EINECS TSIS MUAJ: 609-547-5


MDL TSIS TAU: MFCD01475843

Txhawb tshuaj

Khoom Qhia:

Khoom npe: 2-Piperidin-4-yl-1H-benzoimidazole CAS TSIS: 38385-95-4

Txhais:

2- (4-Piperidinyl) -1H-benzimidazole;

Tshuaj& Cov Khoom Uas Lub Cev:

Cov tsos mob: off-dawb rau daj ntseg daj Khoom

Ntsuas: ≥98.0%

Qhov ceev: 1.167g / cm3

Cov ntsiab lus npau: 441.3 ℃ ntawm 760 mmHg

Flash point: 220.7 ℃

Bilasten Intermediate.

2-Piperidin-4-yl-1H-benzimidazole yog siv los ua reagent hauv cov hluavtaws ntawm 3-amino-1- (5-indanyloxy) -2-propanol derivatives li muaj zog sodium channel blockers rau kev kho mob ischemic stroke. Kuj tseem siv los ua reagent hauv cov hluavtaws ntawm 2,3,5-trisubstituted pyridine derivatives li muaj zog Akt1 / Akt2 dual inhibitors.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam hauv qab patent yog muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm kawg tau txiav txim siab nrog cov neeg yuav khoom.


Cim npe nrov: 2-piperidin-4-yl-1h-benzoimidazole cas 38385-95-4, tuam ntxhab, lwm tus neeg, Hoobkas, yuav, hauv Tshuag

Xa kev nug